IL112955A - 3-) Aminomethyloxadiazolyl (imidazo] A-1,5 [] 1,4 [benzodiazepine-6-ones and their analogues, their preparations and pharmaceutical preparations containing them - Google Patents

3-) Aminomethyloxadiazolyl (imidazo] A-1,5 [] 1,4 [benzodiazepine-6-ones and their analogues, their preparations and pharmaceutical preparations containing them

Info

Publication number
IL112955A
IL112955A IL112955A IL11295595A IL112955A IL 112955 A IL112955 A IL 112955A IL 112955 A IL112955 A IL 112955A IL 11295595 A IL11295595 A IL 11295595A IL 112955 A IL112955 A IL 112955A
Authority
IL
Israel
Prior art keywords
imidazo
dihydro
mmol
oxadiazol
benzodiazepin
Prior art date
Application number
IL112955A
Other languages
English (en)
Hebrew (he)
Other versions
IL112955A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL112955A0 publication Critical patent/IL112955A0/xx
Publication of IL112955A publication Critical patent/IL112955A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL112955A 1994-03-16 1995-03-10 3-) Aminomethyloxadiazolyl (imidazo] A-1,5 [] 1,4 [benzodiazepine-6-ones and their analogues, their preparations and pharmaceutical preparations containing them IL112955A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH78394 1994-03-16
CH1095 1995-01-03

Publications (2)

Publication Number Publication Date
IL112955A0 IL112955A0 (en) 1995-06-29
IL112955A true IL112955A (en) 1998-02-08

Family

ID=25683249

Family Applications (1)

Application Number Title Priority Date Filing Date
IL112955A IL112955A (en) 1994-03-16 1995-03-10 3-) Aminomethyloxadiazolyl (imidazo] A-1,5 [] 1,4 [benzodiazepine-6-ones and their analogues, their preparations and pharmaceutical preparations containing them

Country Status (27)

Country Link
US (1) US5665718A (da)
EP (1) EP0672666B1 (da)
JP (1) JP2690282B2 (da)
KR (1) KR100214800B1 (da)
CN (1) CN1036995C (da)
AT (1) ATE203536T1 (da)
AU (1) AU679608B2 (da)
BG (1) BG62210B1 (da)
CA (1) CA2143246C (da)
CZ (1) CZ288594B6 (da)
DE (1) DE59509432D1 (da)
DK (1) DK0672666T3 (da)
ES (1) ES2160646T3 (da)
FI (1) FI112487B (da)
GR (1) GR3037019T3 (da)
HU (1) HU219987B (da)
IL (1) IL112955A (da)
IS (1) IS4273A (da)
LV (1) LV11327B (da)
MA (1) MA23479A1 (da)
NO (1) NO303731B1 (da)
NZ (1) NZ270685A (da)
PH (1) PH31443A (da)
PT (1) PT672666E (da)
RO (1) RO117698B1 (da)
RU (1) RU2139873C1 (da)
SK (1) SK33995A3 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW349100B (en) * 1994-11-11 1999-01-01 Hoffmann La Roche Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines
US5905176A (en) * 1998-08-28 1999-05-18 Eastman Chemical Company Process for the production of cyclobutyl halides
EP1178990B1 (en) 1999-05-12 2003-01-29 F. Hoffmann-La Roche Ag Imidazodiazepine derivative
US7160880B1 (en) * 1999-05-14 2007-01-09 Cenes Limited Short-acting benzodiazepines
US20060065608A1 (en) * 2004-09-29 2006-03-30 Choate Chris E Process and apparatus for generating useful biomass from organic waste streams
EP1855679B1 (en) * 2005-01-19 2016-06-29 Merck Sharp & Dohme Corp. Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
US8338614B2 (en) * 2005-01-19 2012-12-25 Merck, Sharp & Dohme Corp. Tertiary carbinamines having substituted heterocycles which are active as β-secretase inhibitors for the treatment of alzheimer's disease
CA2607226A1 (en) * 2005-05-16 2007-02-15 Wisys Technology Foundation, Inc. Gabaergic agents to treat memory deficits
CA2657347C (en) 2006-07-10 2014-11-18 Paion Uk Limited Short-acting benzodiazepine salts and their polymorphic forms
GB0613693D0 (en) * 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts (3)
KR101589314B1 (ko) 2007-08-20 2016-01-28 에보텍 인터내셔널 게엠베하 수면 장애의 치료
WO2009024324A2 (en) * 2007-08-20 2009-02-26 Evotec Neurosciences Gmbh Treatment of sleep disorders
US20090054412A1 (en) * 2007-08-20 2009-02-26 John Alan Kemp Treatment of Sleep Disorders
RU2503681C2 (ru) * 2008-09-30 2014-01-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Новое конденсированное производное аминодигидротиазина
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
MA37581B1 (fr) 2012-05-22 2016-07-29 Paion Uk Ltd Compositions comprenant des benzodiazépines à action rapide
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
HUE038169T2 (hu) 2013-09-06 2018-09-28 Aurigene Discovery Tech Ltd 1,2,4-Oxadiazol származékok mint immunomodulátorok
EP4023645A1 (en) 2015-03-10 2022-07-06 Aurigene Discovery Technologies Limited 1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
SG11201706902SA (en) * 2015-03-10 2017-09-28 Aurigene Discovery Tech Ltd 3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
JP2019513796A (ja) 2016-04-14 2019-05-30 パイオン ユーケー リミティド 経口吸入及び経鼻用ベンゾジアゼピン
WO2019061324A1 (en) 2017-09-29 2019-04-04 Curis Inc. CRYSTALLINE FORMS OF IMMUNOMODULATORS
EA202090536A1 (ru) 2017-10-11 2020-07-22 Ориджен Дискавери Текнолоджис Лимитед Кристаллические формы 3-замещенного 1,2,4-оксадиазола
EA202090746A1 (ru) 2017-11-03 2020-08-17 Ориджен Дискавери Текнолоджис Лимитед Двойные ингибиторы путей tim-3 и pd-1
AU2018360389A1 (en) 2017-11-06 2020-05-07 Aurigene Oncology Limited Conjoint therapies for immunomodulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK151808C (da) * 1982-11-16 1988-06-20 Ferrosan As Analogifremgangsmaade til fremstilling af oxadiazolylimidazo-oe1,4aa-benzodiazepinderivater
EP0150040B1 (de) * 1984-01-19 1994-08-31 F. Hoffmann-La Roche Ag Imidazodiazepin-Derivate
AU587802B2 (en) * 1985-03-08 1989-08-31 Ferrosan A/S Novel oxadiazolyl imidazobenzodiazepine derivatives and methods of preparing such compounds
DK476885D0 (da) * 1985-10-17 1985-10-17 Ferrosan As Heterocycliske forbindelser og fremgangsmaader til fremstilling heraf
US4622320A (en) * 1985-05-17 1986-11-11 As Ferrosan Oxadiazolylimidazobenzodiazepine, compositions, and method
DK174086D0 (da) * 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
US4939139A (en) * 1989-07-26 1990-07-03 Merck & Co., Inc. 7-chloro-5,6-dihydro-3-(5-(1,2-dihydroxy-isopropyl)-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4H-imidazo[1,5A][1,4]benzodiazepine
US4904654A (en) * 1989-07-26 1990-02-27 Merck & Co., Inc. 7-chloro-5,6-dihydro-3-(5-(2-hydroxy-isopropyl)-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4H-imidazo[1,5a][1,4]benzodiazepine

Also Published As

Publication number Publication date
IS4273A (is) 1995-09-17
CN1111632A (zh) 1995-11-15
FI112487B (fi) 2003-12-15
CA2143246A1 (en) 1995-09-17
KR100214800B1 (ko) 1999-08-02
BG62210B1 (bg) 1999-05-31
EP0672666B1 (de) 2001-07-25
US5665718A (en) 1997-09-09
FI951251A (fi) 1995-09-17
PT672666E (pt) 2002-01-30
LV11327A (lv) 1996-06-20
CZ66395A3 (en) 1995-10-18
NO950999D0 (no) 1995-03-15
LV11327B (en) 1996-10-20
ES2160646T3 (es) 2001-11-16
SK33995A3 (en) 1995-10-11
DE59509432D1 (de) 2001-08-30
IL112955A0 (en) 1995-06-29
ATE203536T1 (de) 2001-08-15
NO950999L (no) 1995-09-18
FI951251A0 (fi) 1995-03-16
EP0672666A3 (de) 1995-11-08
AU1476095A (en) 1995-09-28
DK0672666T3 (da) 2001-11-12
CZ288594B6 (cs) 2001-07-11
NO303731B1 (no) 1998-08-24
AU679608B2 (en) 1997-07-03
CN1036995C (zh) 1998-01-14
BG99505A (en) 1996-01-31
HU219987B (hu) 2001-10-28
HUT71817A (en) 1996-02-28
HU9500743D0 (en) 1995-04-28
PH31443A (en) 1998-11-03
RO117698B1 (ro) 2002-06-28
KR950032199A (ko) 1995-12-20
RU2139873C1 (ru) 1999-10-20
JP2690282B2 (ja) 1997-12-10
MA23479A1 (fr) 1995-10-01
CA2143246C (en) 2000-08-22
GR3037019T3 (en) 2002-01-31
EP0672666A2 (de) 1995-09-20
RU95103921A (ru) 1996-12-10
JPH07258260A (ja) 1995-10-09
NZ270685A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
IL112955A (en) 3-) Aminomethyloxadiazolyl (imidazo] A-1,5 [] 1,4 [benzodiazepine-6-ones and their analogues, their preparations and pharmaceutical preparations containing them
AU612441B2 (en) Tricyclic compounds
PT760819E (pt) Derivado dicarbonilicos triciclicos
CS249148B2 (en) Method of new imidazodiazepine's derivatives production
EA001143B1 (ru) Трициклические антагонисты вазопрессина
EP1751163A2 (en) Compounds having affinity for dopamine d3 receptor and uses thereof
HU187913B (en) Process for producing alkyl-imidazo-bracket-1,2-c-bracket closed pyrazolo-bracket-3,4-e-bracket closed-pyrimidine derivatives and antipsychotic compositions containing them
IL104099A (en) 3-Transformed Compounds-5-Amino-Imidazo [A-1,5] Quinazoline, Preparation and Pharmaceutical Preparations Containing Them
US5700796A (en) Tricyclic benzazepine vasopressin antagonists
WO1996015129A1 (en) Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
MXPA97003288A (en) Oxazolil- and tiazolil imidazo-benzo- and tienodiazepinas and its use as a medicamen
HU185651B (en) Process for preparing new condensed pyrazine derivatives
CA2204030A1 (en) Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
HRP950125A2 (en) Imidazodiazepines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees